Send to

Choose Destination
See comment in PubMed Commons below
Nat Med. 1996 Dec;2(12):1322-8.

Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer.

Author information

Department of Surgery and Cell Biology, Harvard Medical School, Children's Hospital, Boston, Massachusetts 02115, USA.


The Dunning rat prostatic carcinoma is a model system where cell motility closely correlates with the metastatic phenotype. We have identified a novel gene, upregulated in the highly motile and metastatic Dunning cancer cell lines, that represents a new member of the thymosin-beta family, thymosin beta 15. Transfection of antisense thymosin beta 15 constructs into rat prostatic carcinoma cells demonstrates that this molecule positively regulates cell motility, a critical component of the metastatic pathway. Thymosin beta 15 levels are elevated in human prostate cancer and correlate positively with the Gleason tumor grade. Thymosin beta 15 may represent a potential new biochemical marker for human prostate cancer progression.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center